Fusion Pharmaceuticals Inc. Earnings Per Share, Basic and Diluted
Fusion Pharmaceuticals Inc. reported Earnings Per Share, Basic and Diluted of -$0.46 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-10
- Fusion Pharmaceuticals Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.46.
- Fusion Pharmaceuticals Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.40.
- Fusion Pharmaceuticals Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.45.
- Fusion Pharmaceuticals Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.63.
- Fusion Pharmaceuticals Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.90.
- Fusion Pharmaceuticals Inc. earnings per share, basic and diluted for fiscal 2020 was -$3.62.
- Fusion Pharmaceuticals Inc. earnings per share, basic and diluted for fiscal 2019 was -$8.45.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.46 10-Q · filed 2022-05-10 | |||
| 2021-12-31 | -$0.40 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$0.85 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$1.48 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$1.90 10-K · filed 2022-03-17 |
| 2021-09-30 | -$0.45 10-Q · filed 2021-11-09 | -$1.08 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$1.50 10-Q · filed 2021-11-09 | -$1.83 derived: net income ÷ weighted average shares · filed 2022-05-10 |
| 2021-06-30 | -$0.63 10-Q · filed 2021-08-10 | -$1.05 10-Q · filed 2021-08-10 | -$1.37 derived: net income ÷ weighted average shares · filed 2022-05-10 | -$1.61 derived: net income ÷ weighted average shares · filed 2022-05-10 |
| 2021-03-31 | -$0.42 10-Q · filed 2022-05-10 | -$0.74 derived: net income ÷ weighted average shares · filed 2022-05-10 | -$0.98 derived: net income ÷ weighted average shares · filed 2022-05-10 | -$2.68 derived: net income ÷ weighted average shares · filed 2022-05-10 |
| 2020-12-31 | -$0.32 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$0.56 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$2.38 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$3.62 10-K · filed 2022-03-17 |
| 2020-09-30 | -$0.24 10-Q · filed 2021-11-09 | -$2.48 derived: net income ÷ weighted average shares · filed 2021-11-09 | -$4.30 10-Q · filed 2021-11-09 | -$6.22 derived: net income ÷ weighted average shares · filed 2021-11-09 |
| 2020-06-30 | -$18.91 10-Q · filed 2021-08-10 | -$26.23 10-Q · filed 2021-08-10 | -$31.10 derived: net income ÷ weighted average shares · filed 2021-08-10 | -$31.95 derived: net income ÷ weighted average shares · filed 2021-08-10 |
| 2020-03-31 | -$6.01 10-Q · filed 2021-05-11 | -$10.26 derived: net income ÷ weighted average shares · filed 2021-05-11 | -$10.57 derived: net income ÷ weighted average shares · filed 2021-05-11 | -$12.37 derived: net income ÷ weighted average shares · filed 2021-05-11 |
| 2019-12-31 | -$4.25 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$4.56 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$6.35 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$8.45 10-K · filed 2021-03-25 |
| 2019-09-30 | -$0.31 10-Q · filed 2020-11-10 | -$2.10 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$4.18 10-Q · filed 2020-11-10 | |
| 2019-06-30 | -$1.79 10-Q · filed 2020-08-11 | -$3.89 10-Q · filed 2020-08-11 |